<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The aim of this study was to characterize clinicopathological features of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0235580" disease_type="Neoplastic Process" abbrv="">panmyelosis</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (APMF), <z:hpo ids='HP_0011009'>acute</z:hpo> megakaryoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (AMKL-MF), primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (PMF) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF) in order to provide the keys to the differential diagnosis of bone marrow (BM) <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We compared age, gender, <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, serum <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase level, blood cell counts, blast counts in peripheral blood (PB) and BM, megakaryocyte counts, BM cellularity, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and the karyotypes of patients with APMF (n = 6), AMKL-MF (n = 7), PMF (n = 44), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF (n = 44) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: APMF showed <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> of <z:hpo ids='HP_0000001'>all</z:hpo> three lineages, increase in megakaryocyte count with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and frequent abnormal karyotypes </plain></SENT>
<SENT sid="3" pm="."><plain>AMKL-MF was associated with elevated BM blast counts, decreased BM megakaryocyte count with rare megakaryocytic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and chromosome 21 abnormality </plain></SENT>
<SENT sid="4" pm="."><plain>PMF patients displayed <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, rare blasts in PB/BM, and JAK2 V617F mutation </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF patients showed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> three lineages and recurrent chromosomal abnormalities involving chromosome 5,7,12, and 17 </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Although differential diagnosis among APMF, AMKL-MF, PMF, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-MF is very challenging due to the overlapping clinical and morphological features, meticulous investigation of the patient with respect to <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, blood cell count, PB and BM findings, and karyotype will serve as a guide to correct diagnosis </plain></SENT>
</text></document>